Human microRNAs miR-22, miR-138-2, miR-148a, and miR-488 are associated with panic disorder and regulate several anxiety candidate genes and related pathways

Biological Psychiatry

Volumn 69, Issue 6, 2011, Pages 526-533

  Muiños Gimeno, Margarita ^a,b   Espinosa Parrilla, Yolanda ^a,b,c   Guidi, Monica ^a,b   Kagerbauer, Birgit ^a   Sipilä, Tessa ^f,g   Maron, Eduard ^h,i,j   Pettai, Kristi ⁱ   Kananen, Laura ^f   Navinés, Ricard ^d,e   Martín Santos, Rocío ^d,e   Gratacòs, Mònica ^a   Metspalu, Andres ^h,i   Hovatta, Iiris ^f,g   Estivill, Xavier ^a,b  

^a CENTRE FOR GENOMIC REGULATION CRG   (Spain)

^b UNIVERSITAT POMPEU FABRA   (Spain)

^c INSTITUTE OF EVOLUTIONARY BIOLOGY CSIC UNIVERSITAT POMPEU FABRA   (Spain)

^d INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^e HOSPITAL CLÍNIC   (Spain)

^f UNIVERSITY OF HELSINKI   (Finland)

^g National Institute for Health   (Finland)

^h UNIVERSITY OF TARTU   (Estonia)

ⁱ UNIVERSITY OF TARTU   (Estonia)

^j IMPERIAL COLLEGE LONDON   (United Kingdom)

more..

Author keywords

Anxiety; association study; candidate gene; microRNAs; panic disorder; postranscriptional regulation

Indexed keywords

MICRORNA; MICRORNA 138 2; MICRORNA 148 A; MICRORNA 22; MICRORNA 488; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ADULT; ANXIETY; ARTICLE; BRAIN REGION; ESTONIA; FEMALE; FINLAND; GENE CONTROL; GENETIC TRANSFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROBLASTOMA CELL; PANIC; PHENOTYPE; POPULATION GENETICS; PRIORITY JOURNAL; REPORTER GENE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ANXIETY; CASE-CONTROL STUDIES; CELL LINE, TUMOR; CROSS-CULTURAL COMPARISON; ESTONIA; FEMALE; FINLAND; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; MONOAMINE OXIDASE; NERVE TISSUE PROTEINS; NEUROBLASTOMA; PANIC DISORDER; POLYMORPHISM, SINGLE NUCLEOTIDE; PRO-OPIOMELANOCORTIN; RECEPTORS, CHOLECYSTOKININ; RECEPTORS, GABA-A; RECEPTORS, SEROTONIN, 5-HT2; RGS PROTEINS; SPAIN; TRANSFECTION; YOUNG ADULT;

EID: 79952017623     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2010.10.010     Document Type: Article

References (53)

1. Association AP (1994): Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: Psychiatric Publishing Group.
2. Gratacos M, Sahun I, Gallego X, Amador-Arjona A, Estivill X, Dierssen M (2007): Candidate genes for panic disorder: Insight from human and mouse genetic studies. Genes Brain Behav 6(suppl 1):2-23. (Pubitemid 46744107)
3. Maron E, Nikopensius T, Koks S, Altmae S, Heinaste E, Vabrit K, et al. (2005): Association study of 90 candidate gene polymorphisms in panic disorder. Psychiatr Genet 15:17-24. (Pubitemid 40411566)
4. Rothe C, Gutknecht L, Freitag C, Tauber R, Mossner R, Franke P, et al. (2004): Association of a functional, 1019C>G 5-HT1A receptor gene polymorphism with panic disorder with agoraphobia. Int J Neuropsychopharmacol 7:189-192. (Pubitemid 38823287)
5. Unschuld PG, Ising M, Erhardt A, Lucae S, Kloiber S, Kohli M, et al. (2007): Polymorphisms in the serotonin receptor gene HTR2A are associated with quantitative traits in panic disorder. Am J Med Genet B Neuropsychiatr Genet 144B:424-429. (Pubitemid 46983148)
6. Strug LJ, Suresh R, Fyer AJ, Talati A, Adams PB, Li W, et al. (2010): Panic disorder is associated with the serotonin transporter gene (SLC6A4) but not the promoter region (5-HTTLPR). Mol Psychiatry 15:166-176.
7. Thoeringer CK, Ripke S, Unschuld PG, Lucae S, Ising M, Bettecken T, et al. (2009): The GABA transporter 1 (SLC6A1): A novel candidate gene for anxiety disorders. J Neural Transm 116:649-657.
8. Kennedy JL, Bradwejn J, Koszycki D, King N, Crowe R, Vincent J, et al. (1999): Investigation of cholecystokinin system genes in panic disorder. Mol Psychiatry 4:284-285. (Pubitemid 29292181)
9. Deckert J, Catalano M, Syagailo YV, Bosi M, Okladnova O, Di Bella D, et al. (1999): Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum Mol Genet 8:621-624. (Pubitemid 29139976)
10. Leygraf A, Hohoff C, Freitag C, Willis-Owen SA, Krakowitzky P, Fritze J, et al. (2006): Rgs 2 gene polymorphisms as modulators of anxiety in humans? J Neural Transm 113:1921-1925.
11. Hohoff C, Neumann A, Domschke K, Jacob C, Maier W, Fritze J, et al. (2009): Association analysis of RGS7 variants with panic disorder. J Neural Transm 116:1523-1528.
12. Maron E, Hettema JM, Shlik J (2010): Advances in molecular genetics of panic disorder. Mol Psychiatry 15:681-701.
13. Lupien SJ, McEwen BS, Gunnar MR, Heim C (2009): Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nat Rev Neurosci 10:434-445.
14. Schratt GM, Tuebing F, Nigh EA, Kane CG, Sabatini ME, Kiebler M, et al. (2006): A brain-specific microRNA regulates dendritic spine development. Nature 439:283-289. (Pubitemid 43128846)
15. Smalheiser NR, Lugli G (2009): microRNA regulation of synaptic plasticity. Neuromol Med 11:133-140.
16. Bartel DP (2004): MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116:281-297.
17. Kosik KS (2006): The neuronal microRNA system. Nat Rev Neurosci 7:911-920.
18. Knight JC (2005): Regulatory polymorphisms underlying complex disease traits. J Mol Med 83:97109.
19. Lukiw WJ (2007): Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus. Neuroreport 18:297-300.
20. Wang WX, Rajeev BW, Stromberg AJ, Ren N, Tang G, Huang Q, et al. (2008): The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. J Neurosci 28:1213-1223. (Pubitemid 351186356)
21. Kim J, Inoue K, Ishii J, Vanti WB, Voronov SV, Murchison E, et al. (2007): A microRNA feedback circuit in midbrain dopamine neurons. Science 317:1220-1224.
22. Perkins DO, Jeffries CD, Jarskog LF, Thomson JM, Woods K, Newman MA, et al. (2007): microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder. Genome Biol 8:R27.
23. Hansen T, Olsen L, Lindow M, Jakobsen KD, Ullum H, Jonsson E, et al. (2007): Brain expressed microRNAs implicated in schizophrenia etiology. PLoS ONE 2:e873.
24. Jensen KP, Covault J, Conner TS, Tennen H, Kranzler HR, Furneaux HM (2009): A common polymorphism in serotonin receptor 1B mRNA moderates regulation by miR-96 and associates with aggressive human behaviors. Mol Psychiatry 14:381-389.
25. Muinos-Gimeno M, Montfort M, Bayes M, Estivill X, Espinosa-Parrilla Y (2010): Design and evaluation of a panel of single-nucleotide polymorphisms in microRNA genomic regions for association studies in human disease. Eur J Hum Genet 18:218-226.
26. Bandelow B (1995): Assessing the efficacy of treatments for panic disorder and agoraphobia. II. The Panic and Agoraphobia Scale. Int Clin Psychopharmacol 10:73-81.
27. Arrindell WA, Eisemann M, Richter J, Oei TP, Caballo VE, van der Ende J, et al. (2003): Phobic anxiety in 11 nations. Part I: Dimensional constancy of the five-factor model. Behav Res Ther 41:461-479.
28. Hamilton M (1960): A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-61.
29. Sanchez JJ, Phillips C, Borsting C, Balogh K, Bogus M, Fondevila M, et al. (2006): A. multiplex assay with 52 single nucleotide polymorphisms for human identification. Electrophoresis 27:1713-1724.
30. Pritchard JK, Stephens M, Donnelly P (2000): Inference of population structure using multilocus genotype data. Genetics 155:945-959. (Pubitemid 30397141)
31. Donner J, Pirkola S, Silander K, Kananen L, Terwilliger JD, Lonnqvist J, et al. (2008): An association analysis of murine anxiety genes in humans implicates novel candidate genes for anxiety disorders. Biol Psychiatry 64:672-680.
32. Nelis M, Esko T, Magi R, Zimprich F, Zimprich A, Toncheva D, et al. (2009): Genetic structure of Europeans: A view from the North-East. PLoS ONE 4:e5472.
33. Metspalu A (2004): The Estonian Genome Project. Drug Dev Res 62:97-101.
34. Gonzalez JR, Armengol L, Sole X, Guino E, Mercader JM, Estivill X, et al. (2007): SNPassoc: An R package to perform whole genome association studies. Bioinformatics 23:644-645. (Pubitemid 46522604)
35. Muinos-Gimeno M, Guidi M, Kagerbauer B, Martin-Santos R, Navines R, Alonso P, et al. (2009a): Allele variants in functional microRNA target sites of the neurotrophin-3 receptor gene (NTRK3) as susceptibility factors for anxiety disorders. Hum Mutat 30:1062-1071.
36. Siegel G, Obernosterer G, Fiore R, Oehmen M, Bicker S, Christensen M, et al. (2009): A functional screen implicates microRNA-138-dependent regulation of the depalmitoylation enzyme APT1 in dendritic spine morphogenesis. Nat Cell Biol 11:705-716.
37. Knight JC (2005): Regulatory polymorphisms underlying complex disease traits. J Mol Med Berlin 83:97-109.
38. Rockman MV, Wray GA (2002): Abundant raw material for cis-regulatory evolution in humans. Mol Biol Evol 19:1991-2004. (Pubitemid 35388122)
39. Smoller JW, Tsuang MT (1998): Panic and phobic anxiety: Defining phenotypes for genetic studies. Am J Psychiatry 155:1152-1162. (Pubitemid 28402506)
40. Sklar P, Smoller JW, Fan J, Ferreira MA, Perlis RH, Chambert K, et al. (2008): Whole-genome association study of bipolar disorder. Mol Psychiatry 13:558-569. (Pubitemid 351704939)
41. Wu M, Jolicoeur N, Li Z, Zhang L, Fortin Y, L'Abbe D, et al. (2008): Genetic variations of microRNAs in human cancer and their effects on the expression of miRNAs. Carcinogenesis 29:1710-1716.
42. Betel D, Wilson M, Gabow A, Marks DS, Sander C (2008): The microRNA.org resource: Targets and expression. Nucleic Acids Res 36:D149-D153. (Pubitemid 351149712)
43. Bell CJ, Nutt DJ (1998): Serotonin and panic. Br J Psychiatry 172:465-471. (Pubitemid 28247477)
44. Maron E, Shlik J (2006): Serotonin function in panic disorder: Important, but why? Neuropsychopharmacology 31:1-11. (Pubitemid 43250937)
45. Yalcin B, Willis-Owen SA, Fullerton J, Meesaq A, Deacon RM, Rawlins JN, et al. (2004): Genetic dissection of a behavioral quantitative trait locus shows that RGS2 modulates anxiety in mice. Nat Genet 36:1197-1202. (Pubitemid 41288969)
46. Koenen KC, Amstadter AB, Ruggiero KJ, Acierno R, Galea S, Kilpatrick DG, et al. (2009): RGS2 and generalized anxiety disorder in an epidemiologic sample of hurricane-exposed adults. Depress Anxiety 26:309-315.
47. Oliveira-Dos-Santos AJ, Matsumoto G, Snow BE, Bai D, Houston FP, Whishaw IQ, et al. (2000): Regulation of T cell activation, anxiety, and male aggression by RGS2. Proc Natl Acad Sci U S A 97:12272-12277.
48. Pattyn A, Simplicio N, van Doorninck JH, Goridis C, Guillemot F, Brunet JF (2004): Ascl1/Mash1 is required for the development of central serotonergic neurons. Nat Neurosci 7:589-559.
49. de Pontual L, Népote V, Attié-Bitach T, Al Halabiah H, Trang H, Elghouzzi V, et al. (2003): Noradrenergic neuronal development is impaired by mutation of the proneural HASH-1 gene in congenital central hypoventilation syndrome (Ondine's curse). Hum Mol Genet 12:3173-3180. (Pubitemid 37508888)
50. Taupenot L, Harper KL, O'Connor DT (2003): The chromogranin-secretogranin family. N Engl J Med 348:1134-1149. (Pubitemid 36337325)
51. Tsui CC, Copeland NG, Gilbert DJ, Jenkins NA, Barnes C, Worley PF (1996): Narp, a novel member of the pentraxin family, promotes neurite outgrowth and is dynamically regulated by neuronal activity. J Neurosci 16:2463-2478. (Pubitemid 26122671)
52. Swaab DF, Bao AM, Lucassen PJ (2005): The stress system in the human brain in depression and neurodegeneration. Ageing Res Rev 4:141-194. (Pubitemid 41114861)
53. Keck ME, Kern N, Erhardt A, Unschuld PG, Ising M, Salyakina D, et al. (2008): Combined effects of exonic polymorphisms in CRHR1 and AVPR1B genes in a case/control study for panic disorder. Am J Med Genet B Neuropsychiatr Genet 147B:1196-1204.